share_log

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest

EFFECTOR Therapeutics, Inc.(纳斯达克股票代码:EFTRW)预计空头利率大幅下降
Financial News Live ·  2023/01/01 22:31

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decrease of 23.9% from the November 30th total of 35,200 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 1.7 days.

Effector Therapeutics, Inc.(纳斯达克股票代码:EFTRW — 获取评级)是12月空头利率大幅减少的接受者。截至12月15日,空头利息总额为26,800股,较11月30日的35,200股减少了23.9%。根据16,000股的平均交易量,目前的交易天数比率为1.7天。

eFFECTOR Therapeutics Price Performance

Effector 治疗的价格表现

NASDAQ EFTRW remained flat at $0.16 on Friday. The company has a fifty day moving average of $0.13 and a 200-day moving average of $0.17. eFFECTOR Therapeutics has a fifty-two week low of $0.04 and a fifty-two week high of $0.99.

周五,纳斯达克EFTRW持平至0.16美元。该公司的五十天移动平均线为0.13美元,200天移动平均线为0.17美元。Effector Therapeutics的五十二周低点为0.04美元,五十二周高点为0.99美元。

Featured Stories

精选故事

  • Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Is Kintara Therapeutics A Hidden Gem?
  • Should You Warm up to Generac Stock for the Winter?
  • 免费获取 StockNews.com 关于 Effector Therapeutics(EFTRW)的研究报告
  • MarketBeat:本周回顾 12 月 26 日 — 12 月 30 日
  • 科技之狗:是时候咬一口这些股票了
  • 此次收购会使微软成为熊市买入吗?
  • 金塔拉疗法是隐藏的宝石吗?
  • 你应该为冬天的 Generac Stock 做热身吗?

Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收 Effector Therapeutics 的新闻 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Effector Therapeutics及相关公司的最新新闻和分析师评级的简明每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发